Repros Therapeutics (RPRX) Reports Q4 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $60.71 -1.65%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.16), versus ($0.26) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- LSI Industries (LYTS) Tops Q4 EPS by 3c, Beats on Revenue
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
